BMRNBioMarin Pharmaceuticals Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 12694
Ticker: BMRN
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1999-07-23
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BMRN

Detail

Enriched 2026-08-14 20:47

Market cap: $13,596,620,832.16
Shares outstanding (class): 193,573,759
Shares outstanding (weighted): 193,573,759
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 3,221
Location: NOVATO, CA
Homepage: https://www.biomarin.com
Description: BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Market cap and share counts drift.

Funds holding this security

257 funds · 265 positions · $3.62B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
Dodge & Cox Stock Fund Dodge & Cox Funds	—	$551.89M	0.48%	9,769,625 NS	FIGI
iShares Core S&P Mid-Cap ETF iShares Trust	IJH	$359.31M	0.34%	6,360,660 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$345.77M	0.02%	6,120,870 NS	FIGI
VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS	—	$292.59M	0.40%	5,179,450 NS	FIGI
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$288.62M	1.17%	5,109,245 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$250.50M	0.15%	4,434,414 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$140.25M	0.36%	2,482,741 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$121.18M	0.15%	2,145,115 NS	FIGI
Fidelity Contrafund Fidelity Contrafund	—	$100.13M	0.06%	1,772,542 NS	FIGI
State Street SPDR S&P MidCap 400SM ETF Trust —	—	$81.80M	0.34%	1,447,981 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$79.78M	0.98%	1,412,330 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$79.35M	1.07%	1,404,601 NS	FIGI
First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund	FBT	$77.28M	3.40%	1,368,040 NS	FIGI
Dodge & Cox Balanced Fund Dodge & Cox Funds	—	$53.96M	0.37%	955,200 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 400(TM) M… SPDR SERIES TRUST	SPMD	$53.01M	0.34%	938,453 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBMRN
FIGI_COMPOSITEBBG000CZWZ05
FIGI_SHARE_CLASSBBG001S76R05
CIK0001048477
ISINUS09061G1013
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: BioMarin is a biopharmaceutical company developing therapies for rare diseases, classified under pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.